Comparison of low-level light therapy and combination therapy of 5% minoxidil in the treatment of female pattern hair loss

Author(s):  
Yang Liu ◽  
Lin-lang Jiang ◽  
Fang Liu ◽  
Qian Qu ◽  
Zhe-xiang Fan ◽  
...  
2013 ◽  
Vol 39 (8) ◽  
pp. 1177-1183 ◽  
Author(s):  
Hyojin Kim ◽  
Jee Woong Choi ◽  
Jun Young Kim ◽  
Jung Won Shin ◽  
Seok-jong Lee ◽  
...  

2016 ◽  
Vol 202 (5-6) ◽  
pp. 307-318 ◽  
Author(s):  
In-Su Park ◽  
Phil-Sang Chung ◽  
Jin Chul Ahn

Human adipose-derived mesenchymal stem cells (hASCs) are an attractive cell source for tissue engineering. However, one obstacle to this approach is that the transplanted hASC population can decline rapidly in the recipient tissue. The aim of this study was to investigate the effects of low-level light therapy (LLLT) on transplanted spheroid hASCs in skin flaps of mice. hASCs were cultured in monolayers or spheroids. LLLT, hASCs, spheroids and spheroids transplanted with LLLT were applied to the skin flaps. Healing of the skin flaps was assessed by gross evaluation and by hematoxylin and eosin staining and elastin van Gieson staining. Compared with the spheroid group, skin flap healing was enhanced in the spheroid + LLLT group, including the neovascularization and regeneration of skin appendages. The survival of hASCs was enhanced by decreased apoptosis of hASCs in the skin flaps of the spheroid + LLLT group. The secretion of growth factors was stimulated in the spheroid + LLLT group compared with the ASC and spheroid groups. These data suggest that LLLT was an effective biostimulator of spheroid hASCs in the skin flaps, enhancing the survival of hASCs and stimulating the secretion of growth factors.


2018 ◽  
Vol 13 ◽  
pp. S95-S96
Author(s):  
Dorothee Weihrauch ◽  
Janine Struve ◽  
Alina Brener ◽  
Natalie Mcvey ◽  
Rhett Nances ◽  
...  

Author(s):  
Nachiket Madhukarrao Palaskar ◽  
Nitin Dinkar Chaudhari ◽  
Garima Laxminarayan Balpande ◽  
Swapna Subhash Khatu

<p class="abstract"><strong>Background:</strong> Female pattern hair loss (FPHL) is a common form of nonscarring hair loss. We compared the usefulness and safety of topical minoxidil alone with combination of oral spironolactone and topical minoxidil in the treatment of FPHL.</p><p class="abstract"><strong>Methods:</strong> This prospective, single-centre, randomised open label study over 100 patients attending tertiary care hospital in Mumbai during period December 2011 to June 2012. The data were entered into SPSS version 21 for analysis. Data collected were coded and described as frequency and percentage for qualitative data and means and standard deviation for quantitative data. Statistical analysis was done using chi-square and student t test. Statistical significance was considered if p value was less than 0.05.<strong></strong></p><p class="abstract"><strong>Results:</strong> There were 48 patients in Group I and 46 patients in Group II. At 6 months, significantly higher mean Sinclair grade was observed among Group I patients as compared to Group II patients (2.85±0.68 vs 2.56±0.50, p=0.02). We observed a significant improvement in women’s androgenetic alopecia quality of life questionnaire in Group I patients at 12 months after treatment (26.93±2.25 vs 23.47±2.95, p&lt;0.001). Minoxidil and spironolactone were tolerated well by the patients.</p><p class="abstract"><strong>Conclusions:</strong> Combination therapy of topical minoxidil and oral spironolactone has an additive effect. However, plateau of effectiveness of the combination therapy in normoandrogenic patients at 6 months of therapy was observed. We recommend the combination for 6 months and continuation of therapy with minoxidil only.</p>


2021 ◽  
Vol Volume 15 ◽  
pp. 2803-2811
Author(s):  
Ana Marta ◽  
Pedro Manuel Baptista ◽  
João Heitor Marques ◽  
Daniel Almeida ◽  
Diana José ◽  
...  

2010 ◽  
Vol 15 (4) ◽  
pp. 048005 ◽  
Author(s):  
Daniel Barolet ◽  
Pascale Duplay ◽  
Hélène Jacomy ◽  
Mathieu Auclair

Sign in / Sign up

Export Citation Format

Share Document